Shenzhen CrystalO Biopharma Technology Co., Ltd.
PrivateLast Round
Pre Seed
Mar 13, 2020
Total Funding Raised
$3.29M
Company Overview
Shenzhen CrystalO Biopharma Technology Co., Ltd. operates in Healthcare & Life Sciences and is based in Shenzhen. Its latest recorded funding round was a Pre Seed round in March 2020.
Shenzhen CrystalO Biopharma Technology Co., Ltd. is a biotechnology company that specializes in the research and development of innovative ion channel medicines for neurological, psychiatric, chronic kidney, and cardiovascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shenzhen CrystalO Biopharma Technology Co., Ltd. Comparables
Compare Shenzhen CrystalO Biopharma Technology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| leadXpro AG | 81% | |
| Ligand Pharmaceuticals | 77% | |
| Abilita Therapeutics | 76% |
For institutional investors. Book with your work email.
Shenzhen CrystalO Biopharma Technology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Mar 13, 2020 | ||||
| Early Funding | Apr 15, 2019 | ||||
| Angel | Nov 27, 2018 |
For institutional investors. Book with your work email.
Shenzhen CrystalO Biopharma Technology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CAS Star | Pre Seed, Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 13, 2020
$2.86M round led by CAS Star
- Apr 15, 2019
Company raised an early funding round.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingAug 10, 2026
On Aug 10th '26 in China, Crystalobio and Almirall announce a collaboration to jointly initiate drug-discovery R&D, combining ion-channel expertise with medical-dermatology research and clinical-development experience to develop innovative drug candidates for skin diseases.
For institutional investors. Book with your work email.
Shenzhen CrystalO Biopharma Technology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Shenzhen CrystalO Biopharma Technology Co., Ltd.'s valuation, stock price, and market status.
Is Shenzhen CrystalO Biopharma Technology Co., Ltd. a public or private company?
Shenzhen CrystalO Biopharma Technology Co., Ltd. is a private company.
What is the current stock price of Shenzhen CrystalO Biopharma Technology Co., Ltd.?
Shenzhen CrystalO Biopharma Technology Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Shenzhen CrystalO Biopharma Technology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Shenzhen CrystalO Biopharma Technology Co., Ltd. worth (valuation)?
Valuation information for Shenzhen CrystalO Biopharma Technology Co., Ltd. is not publicly available.
Can I buy Shenzhen CrystalO Biopharma Technology Co., Ltd. stock?
Shenzhen CrystalO Biopharma Technology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Shenzhen CrystalO Biopharma Technology Co., Ltd.'s last funding round?
Shenzhen CrystalO Biopharma Technology Co., Ltd.'s most recent funding round was Pre Seed on March 13, 2020.
Who are the main investors in Shenzhen CrystalO Biopharma Technology Co., Ltd.?
Key investors in Shenzhen CrystalO Biopharma Technology Co., Ltd. include CAS Star.
Will Shenzhen CrystalO Biopharma Technology Co., Ltd. IPO soon?
No public IPO plans have been announced for Shenzhen CrystalO Biopharma Technology Co., Ltd..
How can I track Shenzhen CrystalO Biopharma Technology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Shenzhen CrystalO Biopharma Technology Co., Ltd.'s shares on secondary markets.